clavulanic acid has been researched along with Myasthenia Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelucci, E; Cesarini, M; Vernia, P | 1 |
| Asole, D; Lakkas, Y; Shah, A; Shaunbhag, P; Shrivastava, M; Sundar, U; Vaidya, M | 1 |
2 other study(ies) available for clavulanic acid and Myasthenia Gravis
| Article | Year |
|---|---|
Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor alpha inhibitors and conventional immunosuppressi
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Clavulanic Acid; Crohn Disease; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Infliximab; Myasthenia Gravis; Pneumonia; Prednisolone; Tumor Necrosis Factor-alpha; Uveitis | 2010 |
Experience with patients with anti-MUSK antibody positive myasthenia gravis.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies; Autoantibodies; Child; Clavulanic Acid; Facial Muscles; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Muscle Weakness; Muscular Atrophy; Myasthenia Gravis; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Treatment Outcome | 2010 |